Jian-Ming Xu
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Hepatology top 5%
- Molecular Biology
- Pathology and Forensic Medicine top 10%
- Co-authors
- Angelo ParadisoAmalia AzzaritiRongrui LiuZhiyuan HuLianpeng ChangYun ZhangRu JiaGairong Zhang
- Topics
- Colorectal Cancer Treatments and Studies (10 papers)Cancer Treatment and Pharmacology (5 papers)HER2/EGFR in Cancer Research (4 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Jian-Ming Xu
15 papers receiving 805 citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 578
- Pulmonary and Respiratory Medicine 341
- Hepatology 176
- Molecular Biology 167
- Pathology and Forensic Medicine 152
Countries citing papers authored by Jian-Ming Xu
This map shows the geographic impact of Jian-Ming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian-Ming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian-Ming Xu more than expected).
Fields of papers citing papers by Jian-Ming Xu
This network shows the impact of papers produced by Jian-Ming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian-Ming Xu. The network helps show where Jian-Ming Xu may publish in the future.
Co-authorship network of co-authors of Jian-Ming Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Jian-Ming Xu. A scholar is included among the top collaborators of Jian-Ming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian-Ming Xu. Jian-Ming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Studybreakdown → | 368 |
| 2 | 64 | |
| 3 | 7 | |
| 4 | 22 | |
| 5 | 33 | |
| 6 | 10 | |
| 7 | 96 | |
| 8 | 22 | |
| 9 | 16 | |
| 10 | 14 | |
| 11 | 48 | |
| 12 | 44 | |
| 13 | 60 | |
| 14 | 11 | |
| 15 | 3 |
About Jian-Ming Xu
Jian-Ming Xu is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 818 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (5 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Hepatology (176 citations), Oncology (578 citations) and Pulmonary and Respiratory Medicine (341 citations). Jian-Ming Xu has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Angelo Paradiso, Amalia Azzariti, Rongrui Liu, Zhiyuan Hu, Lianpeng Chang, Yun Zhang, Ru Jia, Gairong Zhang, Yan Wang and Xin Yi. Their work appears in journals such as American Journal of Epidemiology, Clinical Cancer Research and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.